Partnerships & Mergers
-
Alcon-Lensar merger collapses as FTC signals opposition to USD356 million deal
The deal aimed to combine Lensar’s innovative cataract surgery technologies with Alcon’s existing portfolio, potentially creating a dominant force in the femtosecond laser-assisted cataract surgery market.
-
C37 partners with India’s Sir Ganga Ram Hospital to expand specialized vascular care in UAE
The partnership will bring select consultant vascular and endovascular surgeons from Sir Ganga Ram Hospital’s IVES to C37’s Dubai facility.
-
Africa CDC partners with GAFFI to launch first continental strategy against fungal diseases
The summit concluded with stakeholders committing to strengthen surveillance systems, build diagnostic capacity, and expand access to treatment throughout the continent.
-
Idorsia collaborates with Pharmalink to bring insomnia treatments to Gulf markets
Through strategic partnerships similar to the Pharmalink agreement, the medication has already reached patients in China, Hong Kong, Japan, and various Latin American markets.
-
Egypt partners with Roche to launch national digital pathology network for faster cancer detection
The network will create a nationwide digital infrastructure that enhances diagnostic accuracy while supporting more effective treatment planning for patients throughout Egypt.
-
Africa CDC signs historic Health Security partnership agreement with ECDC in Ethiopia
The partnership will focus on joint initiatives addressing antimicrobial resistance, vaccine-preventable diseases, and emerging health threats.
-
JOOTRH partners with global health researchers to tackle maternal mortality
Through its partnership with JOOTRH, CHAMPS works directly with clinicians in the Paediatrics and Maternity Units to advance research that improves outcomes for mothers and newborns.
-
Africa CDC partners with Japan Institute for Health Security to strengthen continental disease preparedness
The agreement establishes a structured framework for tackling emerging and re-emerging public health threats while strengthening pandemic prevention and preparedness systems.
-
Pfizer enters China’s weight-loss market as regulators approve the GLP-1 drug Xianweiying
Pfizer secured marketing rights to the GLP-1 compound ecnoglutide through a partnership with Hangzhou-based Sciwind Biosciences announced last month.
-
BioDuro expands API production to Taiwan through new joint venture with Cenra
The venture aims to deliver comprehensive active pharmaceutical ingredient (API) services, covering everything from initial development stages through full-scale commercial production.